Ceftobiprole medocaril is a fifth-generation[2] cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, Pseudomonas aeruginosa, and enterococci.
More Information Supplier PageCeftobiprole medocaril is a fifth-generation[2] cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, Pseudomonas aeruginosa, and enterococci.
More Information Supplier PageCeftobiprole medocaril is a fifth-generation[2] cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, Pseudomonas aeruginosa, and enterococci.
More Information Supplier PageChaetocin is a histone methyltransferase SUV39H1 inhibitor (IC50 = 0.8 ??M). Induces apoptosis in myeloma cell lines in vitro; exhibits antiproliferative activity in a mouse myeloma model in vivo.
More Information Supplier PageChaetocin is a histone methyltransferase SUV39H1 inhibitor (IC50 = 0.8 ??M). Induces apoptosis in myeloma cell lines in vitro; exhibits antiproliferative activity in a mouse myeloma model in vivo.
More Information Supplier PageC646 is a selective p300/CREB-binding protein (CBP) inhibitor (Ki = 400 nM).
More Information Supplier PageC646 is a selective p300/CREB-binding protein (CBP) inhibitor (Ki = 400 nM).
More Information Supplier PageC646 is a selective p300/CREB-binding protein (CBP) inhibitor (Ki = 400 nM).
More Information Supplier Page
